172 related articles for article (PubMed ID: 30312021)
1. Efficient CRISPR/Cas9-Mediated Mutagenesis in Primary Murine T Lymphocytes.
Huang B; Johansen KH; Schwartzberg PL
Curr Protoc Immunol; 2019 Feb; 124(1):e62. PubMed ID: 30312021
[TBL] [Abstract][Full Text] [Related]
2. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line.
Chu VT; Graf R; Wirtz T; Weber T; Favret J; Li X; Petsch K; Tran NT; Sieweke MH; Berek C; Kühn R; Rajewsky K
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12514-12519. PubMed ID: 27729526
[TBL] [Abstract][Full Text] [Related]
3. Ribonucleoprotein Transfection for CRISPR/Cas9-Mediated Gene Knockout in Primary T Cells.
Oh SA; Seki A; Rutz S
Curr Protoc Immunol; 2019 Feb; 124(1):e69. PubMed ID: 30334617
[TBL] [Abstract][Full Text] [Related]
4. Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing.
Bierle CJ; Anderholm KM; Wang JB; McVoy MA; Schleiss MR
J Virol; 2016 Aug; 90(15):6989-6998. PubMed ID: 27226370
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-Mediated In Vitro Mutagenesis in GC-Like B Cells.
Chu VT; Graf R; Rajewsky K
Methods Mol Biol; 2017; 1623():135-145. PubMed ID: 28589354
[TBL] [Abstract][Full Text] [Related]
6. Rapid and Efficient Gene Editing for Direct Transplantation of Naive Murine Cas9
Majumder S; Jugovic I; Saul D; Bell L; Hundhausen N; Seal R; Beilhack A; Rosenwald A; Mougiakakos D; Berberich-Siebelt F
Front Immunol; 2021; 12():683631. PubMed ID: 34367143
[TBL] [Abstract][Full Text] [Related]
7. Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes.
Nakagawa Y; Sakuma T; Sakamoto T; Ohmuraya M; Nakagata N; Yamamoto T
BMC Biotechnol; 2015 May; 15():33. PubMed ID: 25997509
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
Hussain B; Lucas SJ; Budak H
Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
[TBL] [Abstract][Full Text] [Related]
9. Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy.
Klepsch V; Pommermayr M; Humer D; Brigo N; Hermann-Kleiter N; Baier G
Cell Commun Signal; 2020 Jan; 18(1):8. PubMed ID: 31937317
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9-mediated efficient genome editing via protoplast-based transformation in yeast-like fungus Aureobasidium pullulans.
Zhang Y; Feng J; Wang P; Xia J; Li X; Zou X
Gene; 2019 Aug; 709():8-16. PubMed ID: 31132514
[TBL] [Abstract][Full Text] [Related]
11. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
12. Genome Editing in Mouse Embryos with CRISPR/Cas9.
Scott GJ; Gruzdev A
Methods Mol Biol; 2019; 1960():23-40. PubMed ID: 30798518
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9-mediated genome editing in apple and grapevine.
Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
[TBL] [Abstract][Full Text] [Related]
14. Simple, fast and efficient iTOP-mediated delivery of CRISPR/Cas9 RNP in difficult-to-transduce human cells including primary T cells.
Kholosy WM; Visscher M; Ogink K; Buttstedt H; Griffin K; Beier A; Gerlach JP; Molenaar JJ; Geijsen N; de Boer M; Chatsisvili A
J Biotechnol; 2021 Sep; 338():71-80. PubMed ID: 34271056
[TBL] [Abstract][Full Text] [Related]
15. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
Tang L; Gong M; Zhang P
Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
[TBL] [Abstract][Full Text] [Related]
16. Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9.
Abrahimi P; Chang WG; Kluger MS; Qyang Y; Tellides G; Saltzman WM; Pober JS
Circ Res; 2015 Jul; 117(2):121-8. PubMed ID: 25940550
[TBL] [Abstract][Full Text] [Related]
17. Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
Brunetti L; Gundry MC; Kitano A; Nakada D; Goodell MA
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708546
[TBL] [Abstract][Full Text] [Related]
18. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 mediates efficient conditional mutagenesis in Drosophila.
Xue Z; Wu M; Wen K; Ren M; Long L; Zhang X; Gao G
G3 (Bethesda); 2014 Sep; 4(11):2167-73. PubMed ID: 25193494
[TBL] [Abstract][Full Text] [Related]
20. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
